Tag: observed

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical…

GlobeNews Wire GlobeNews Wire

2025 IBM X-Force Threat Index: Large-Scale Credential Theft Escalates, Threat Actors Pivot to Stealthier Tactics

Nearly half of all cyberattacks resulted in stolen data or credentialsIdentity abuse…

PRNW Agency PRNW Agency

EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements

PROVIDENCE, R.I., Feb. 27, 2025 /PRNewswire/ -- EpiVax, Inc. proudly announces the…

PRNW Agency PRNW Agency